// COMPANY
Sofie Biosciences
SECTOR BIOTECHMENTIONS 1LAST SEEN OCTOBER 5, 2026
// RECENT MENTIONS
// SIGNALS
1 SIGNAL
01
m_and_a·Axios Pro Rata·OCTOBER 5, 2026
“GE HealthCare (Nasdaq: GEHC) agreed to buy Sofie Biosciences, a Dulles, Va.-based maker of cancer scan chemicals, for $945m in cash.”
AI-extracted from podcast / newsletter / paper summaries. May contain errors.